The leading market experts have placed a mean price target of $24.89 on Boston Scientific Corporation (NYSE:BSX) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $0.27 a share for the upcoming quarter and $1.09 for the current fiscal. Technical View The technical analysis of Boston Scientific Corporation C plainly substantiates that the 50-day moving average of Boston Scientific Corporation C is $23.12, and stock is hovering 1.14 or +4.92% distant from $23.12. It is noted that the 200-day MA is $20.03, and Boston Scientific Corporation C stock is $4.23 or +21.12% off from this point. Boston Scientific Corporation (NYSE:BSX) 52-week high is $24.45 and the 52-week low is $14.18. This explains if the stock moves $-0.19, it will post a 52-week high. In event of $+71.09% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Boston Scientific Corporation C, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Boston Scientific Corporation (NYSE:BSX) ratio came in at N/A. The stock last ended the trading session at $24.26 and registered a market cap of $32.92B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Boston Scientific Corporation (NYSE:BSX) PEG ratio is at 1.75.
1 Chart Pattern Every Investor Should Know